PCM
AGL icon

Prelude Capital Management’s Agilon Health AGL Stock Holding History

Prelude Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
+5,564
New +$364K 0.04% 458

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Prelude Capital Management's AGL Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Agilon Health (AGL) in Q2 2026: 5,564 shares worth $596K. The stake represents 0.04% of the portfolio and ranks #458 among its holdings.

179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Prelude Capital Management held 5,564 shares of Agilon Health worth $596K as of Q2 2026.
  • Agilon Health was a new Prelude Capital Management position in Q2 2026.
  • Agilon Health made up 0.04% of Prelude Capital Management's portfolio in Q2 2026, its #458 holding.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.